当前位置: 首页 > 期刊 > 《中国医学创新》 > 2025年第11期
编号:2317379
四君子汤加减结合FOLFOX4方案化疗对晚期 结直肠癌患者血清肿瘤标志物水平、KPS 评分的影响
http://www.100md.com 2025年6月4日 中国医学创新 2025年第11期
     Effect of Modified Sijunzi Decoction Combined with FOLFOX4 Regimen Chemotherapy on Serum Tumor Marker Levels and KPS Score in Patients with Advanced Colorectal Cancer/XIAO Lu, YI Yanfei, ZHONG Huan, WANG Zhiqiang,XIAO Wei, LUO Nengping.//Medical Innovation of China, 2025, 22(11): 026-029

    [Abstract]Objective: To analyze the effect of modified Sijunzi Decoction combined with FOLFOX4 chemotherapy on patients with advanced colorectalcancer.Method: A total of 60 patients withadvancedcolorectal cancer admitted to Ganzhou Cancer Hospital from January 2022 to December 2023 were randomly divided into two groups, with 30 patients in each group.The control group received FOLFOX4 regimen chemotherapy, and the observationgroupreceivedmodified SijunziDecoctiontreatmentonthebasis ofthecontrol group,allofwhich were treated for 4courses.The clinicalefficacy,tumor markers,immune function,healthstatusandincidenceof adverse reactions were compared between thetwo groups.Result:The totalefective rate of treatment in observation group washigherthanthat incontrol groupandthe incidenceofadversereactions waslowerthanthat incontrol group ......

您现在查看是摘要页,全文长 13347 字符